Correlation Between Microsoft and Purple Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Purple Biotech, you can compare the effects of market volatilities on Microsoft and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Purple Biotech.

Diversification Opportunities for Microsoft and Purple Biotech

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Microsoft and Purple is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Microsoft i.e., Microsoft and Purple Biotech go up and down completely randomly.

Pair Corralation between Microsoft and Purple Biotech

Given the investment horizon of 90 days Microsoft is expected to generate 0.25 times more return on investment than Purple Biotech. However, Microsoft is 3.98 times less risky than Purple Biotech. It trades about 0.1 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.07 per unit of risk. If you would invest  22,345  in Microsoft on August 31, 2024 and sell it today you would earn a total of  20,001  from holding Microsoft or generate 89.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy77.41%
ValuesDaily Returns

Microsoft  vs.  Purple Biotech

 Performance 
       Timeline  
Microsoft 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Microsoft and Purple Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft and Purple Biotech

The main advantage of trading using opposite Microsoft and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.
The idea behind Microsoft and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities